EP0960118A4 - Nucleotide and protein sequences of liver activin/inhibin and methods based thereon - Google Patents

Nucleotide and protein sequences of liver activin/inhibin and methods based thereon

Info

Publication number
EP0960118A4
EP0960118A4 EP97950609A EP97950609A EP0960118A4 EP 0960118 A4 EP0960118 A4 EP 0960118A4 EP 97950609 A EP97950609 A EP 97950609A EP 97950609 A EP97950609 A EP 97950609A EP 0960118 A4 EP0960118 A4 EP 0960118A4
Authority
EP
European Patent Office
Prior art keywords
inhibin
nucleotide
protein sequences
methods based
liver activin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP97950609A
Other languages
German (de)
French (fr)
Other versions
EP0960118A1 (en
Inventor
Jeffrey Bonadio
Jianming Fang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
University of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan filed Critical University of Michigan
Publication of EP0960118A1 publication Critical patent/EP0960118A1/en
Publication of EP0960118A4 publication Critical patent/EP0960118A4/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP97950609A 1996-11-20 1997-11-20 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon Pending EP0960118A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75291996A 1996-11-20 1996-11-20
US752919 1996-11-20
PCT/US1997/020882 WO1998022492A1 (en) 1996-11-20 1997-11-20 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon

Publications (2)

Publication Number Publication Date
EP0960118A1 EP0960118A1 (en) 1999-12-01
EP0960118A4 true EP0960118A4 (en) 2001-08-08

Family

ID=25028437

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97950609A Pending EP0960118A4 (en) 1996-11-20 1997-11-20 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon

Country Status (5)

Country Link
EP (1) EP0960118A4 (en)
JP (1) JP2001505420A (en)
AU (1) AU743792B2 (en)
CA (1) CA2272545A1 (en)
WO (1) WO1998022492A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002953327A0 (en) * 2002-12-12 2003-01-09 Monash University Methods of diagnosing prognosing and treating activin associated diseases and conditions
AU2005247871A1 (en) 2004-04-27 2005-12-08 Research Development Foundation Antagonism of TGF-beta superfamily receptor signaling
EP1764117A1 (en) 2005-09-20 2007-03-21 Zimmer GmbH Implant for the repair of a cartilage defect and method for manufacturing the implant
WO2010144696A1 (en) 2009-06-11 2010-12-16 Burnham Institute For Medical Research Directed differentiation of stem cells

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FANG J ET AL: "GENES CODING FOR MOUSE ACTIVIN BETAC AND BETAE ARE CLOSELY LINKED AND EXIHIBIT A LIVER-SPECIFIC EXPRESSION PATTERN IN ADULT TISSUES", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,US,ACADEMIC PRESS INC. ORLANDO, FL, vol. 231, 1997, pages 655 - 661, XP000882729, ISSN: 0006-291X *
HOETTEN G ET AL: "CLONING OF A NEW MEMBER OF THE TGF-BETA FAMILY: A PUTATIVE NEW ACTIVIN BETAC CHAIN", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,US,ACADEMIC PRESS INC. ORLANDO, FL, vol. 206, no. 2, 17 January 1995 (1995-01-17), pages 608 - 613, XP000857726, ISSN: 0006-291X *
See also references of WO9822492A1 *

Also Published As

Publication number Publication date
EP0960118A1 (en) 1999-12-01
AU5356798A (en) 1998-06-10
WO1998022492A1 (en) 1998-05-28
JP2001505420A (en) 2001-04-24
CA2272545A1 (en) 1998-05-28
AU743792B2 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
HUP0301829A3 (en) Nucleotidok and protein sequences of nogo genes and methods based thereon
AU2008799A (en) Detection of transitions in video sequences
IL134480A0 (en) Kay - an immune system protein and dna sequences encoding the same
EP1036198A4 (en) Method for creating polynucleotide and polypeptide sequences
GB9720148D0 (en) Gene silencing materials and methods
SG105506A1 (en) Gene sequencer and methods
IL132704A0 (en) Methods and compositions for the selective modification of nucleic acids
HUP9901321A3 (en) Methods and compositions for determining the sequence of nucleic acid molecules
EP1027450A4 (en) Method of dna shuffling
EP0817798A4 (en) Nucleotide and protein sequences of lats genes and methods based thereon
IL135338A0 (en) Methods and compositions for the selective modification of nucleic acids
PL335232A1 (en) Polyester of low peeling susceptibility
AU3347500A (en) Methods and kits for characterizing gc-rich nucleic acid sequences
HUP0100668A3 (en) Virulence-associated nucleic sequences and uses thereof
AU6778198A (en) Methods for identifying variations in polynucleotide sequences
EP1071698A4 (en) Nucleic acid sequences and proteins associated with aging
AU3911897A (en) Phospholipase d and dna sequences
EP0960118A4 (en) Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
EP1140978A4 (en) Methods of identifying antigen gene sequences
AU4318199A (en) Nucleotide and protein sequences of gpr1 and methods based thereon
AU4910299A (en) Gene and protein involved in liver regeneration
IL123513A0 (en) Identification of bases in nucleic acid sequences
AU3207799A (en) Mpr-related abc transporter encoding nucleic acids and methods of use thereof
PL336487A1 (en) Mammalian glucuronil c5-epimerase encoding dna sequence and method of obtaining same
AU6550598A (en) Antithrombin protein and dna sequences

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990618

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07H 21/04 A, 7C 12N 15/00 B, 7C 12N 5/10 B, 7C 12N 5/16 B, 7C 07K 14/575 B

A4 Supplementary search report drawn up and despatched

Effective date: 20010622

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

18W Application withdrawn

Effective date: 20040506

D18W Application withdrawn (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

R18W Application withdrawn (corrected)

Effective date: 20040506